17-4539629-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_014520.4(MYBBP1A):c.3773C>T(p.Pro1258Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 1,613,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014520.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBBP1A | NM_014520.4 | c.3773C>T | p.Pro1258Leu | missense_variant | 26/26 | ENST00000254718.9 | NP_055335.2 | |
MYBBP1A | NM_001105538.2 | c.3773C>T | p.Pro1258Leu | missense_variant | 26/27 | NP_001099008.1 | ||
MYBBP1A | XM_011523616.3 | c.3017C>T | p.Pro1006Leu | missense_variant | 21/21 | XP_011521918.1 | ||
MYBBP1A | XM_024450536.2 | c.*273C>T | 3_prime_UTR_variant | 25/25 | XP_024306304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBBP1A | ENST00000254718.9 | c.3773C>T | p.Pro1258Leu | missense_variant | 26/26 | 1 | NM_014520.4 | ENSP00000254718.4 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152046Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251242Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135786
GnomAD4 exome AF: 0.0000589 AC: 86AN: 1460992Hom.: 0 Cov.: 36 AF XY: 0.0000674 AC XY: 49AN XY: 726676
GnomAD4 genome AF: 0.000132 AC: 20AN: 152046Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74272
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at